Source of the article: PharmaHealth News
Note: The fiscal year start dates for major companies differ from the calendar year, so there may be inconsistencies between fiscal quarters, fiscal years, and the calendar year. Companies may announce their performance on a quarterly or semi-annual basis.Johnson & Johnson announced its Q2 2023 financial report, showing a significant increase in sales for the medical technology business. Quarterly sales reached $25.53 billion, compared to $24.02 billion in the same period last year, representing a 6.3% year-over-year growth. Net profit was $5.144 billion, up from $4.814 billion in the previous year, marking a 6.9% increase. By segment, pharmaceutical sales were $13.731 billion, a 3.1% increase. Medical device sales amounted to $7.788 billion, growing by 12.9%. Consumer health sales reached $4.011 billion, reflecting a 5.4% growth.Medtronic Reports First Quarter Earnings for Fiscal Year 2023 Ending July 28. Quarterly net sales were $7.702 billion, an increase of 4.5% compared to $7.371 billion in the same period last year. Sales in the cardiac device division grew by 1%, reaching $2.77 billion. Net profit attributable to the company for the quarter was $791 million, compared to $929 million in the same period last year.Danaher Reports Second Quarter 2023 Results. Quarterly sales were $7.157 billion, compared to $7.751 billion in the same period last year. Net income attributable to common shareholders for the quarter was $1.106 billion, compared to $1.658 billion in the same period last year.Abbott Reports Q2 2023 Earnings. Quarterly revenue was $9.978 billion, compared to $11.257 billion in the same period last year, a decrease of 11.4% year-over-year. Net profit was $1.375 billion, compared to $20.18 billion in the same period last year, a decrease of 31.8% year-over-year. By business segment, nutrition business revenue was $2.076 billion, an increase of 6.3% year-over-year; diagnostics business revenue was $2.317 billion, a decrease of 46% year-over-year. Generic drug business sales were $1.287 billion, an increase of 5.2% year-over-year; medical device business sales were $4.295 billion, an increase of 13.5% year-over-year.
Siemens Healthineers Releases Q3 2023 Financial Results Ended June 30, 2023. Quarterly revenue reached €5.201 billion (approximately $5.62 billion), compared to €5.186 billion in the same period last year. Adjusted EBIT profit was €740 million, versus €765 million in the prior-year quarter. Quarterly net profit amounted to €451 million, up from €364 million in the same period last year.
Fresenius Group (Fresenius SE & Co. KGaA) Announces Q2 2023 Financial Results. Quarterly revenue reached €10.359 billion, compared to €10.018 billion in the same period last year. Operating profit was €543 million, down from €845 million in the previous year. Net profit attributable to the company was €375 million, compared to €450 million in the prior year. Among operating companies, Fresenius Kabi reported revenue of €2.001 billion, a 6% increase year-over-year. Fresenius Helios Clinics generated revenue of €3.113 billion, also a 6% increase year-over-year. Among investment companies, Fresenius Vamed reported revenue of €531 million, a 6% decrease year-over-year. Fresenius Medical Care achieved revenue of €4.825 billion (approximately $5.22 billion), representing a 1% year-over-year growth; net profit was €175 million, up 51% year-over-year.
Medical device and equipment manufacturer Stryker reported its Q2 2023 financial results. Net sales for the quarter reached $4.996 billion, compared to $4.493 billion in the same period last year. Quarterly net profit was $738 million, up from $656 million in the prior-year quarter.BD Reports Q2 2023 Earnings. Revenue for the quarter was $4.878 billion, compared to $4.641 billion in the same period last year. Net income attributable to common shareholders for the quarter was $392 million, compared to $338 million in the same period last year.Philips Reports Q2 2023 Results. Quarterly Sales Reach €4.47 Billion (Approx. $4.83 Billion), Up 7% Year-over-Year. Net Profit at €74 Million, Compared to a Net Loss of €20 Million in the Same Period Last Year. Adjusted EBITDA Increased to €453 Million.GE HealthCare Reports Q2 2023 Financial Results. Total revenue for the quarter was $4.817 billion, compared to $4.484 billion in the same period last year. Net income attributable to common shareholders for the quarter was $418 million, compared to $485.8 million in the same period last year.
Roche Announces Financial Results for the First Half of 2023. Sales revenue for the period was 29.779 billion Swiss francs, compared to 32.295 billion Swiss francs in the same period last year, representing an 8% year-on-year decrease. Operating profit for the period was 9.764 billion Swiss francs, compared to 11.547 billion Swiss francs in the same period last year, marking a 15% year-on-year decline. Net profit attributable to shareholders of the company was 7.137 billion Swiss francs, compared to 8.53 billion Swiss francs in the same period last year. Pharmaceutical business sales revenue amounted to 22.681 billion Swiss francs, with an operating profit of 10.085 billion Swiss francs. Diagnostics business sales revenue reached 7.098 billion Swiss francs (approximately 8.02 billion U.S. dollars), with an operating profit of 1.567 billion Swiss francs.
Thermo Fisher Scientific Announces Financial Results for the Second Quarter of 2023. Quarterly revenue was $10.687 billion, compared to $10.97 billion in the same period last year. Net income attributable to the company for the quarter was $1.361 billion, compared to $1.664 billion in the same period last year. Specifically, life sciences business revenue was $2.463 billion, laboratory products and services revenue was $5.831 billion, specialty diagnostics business revenue was $1.109 billion, and analytical instruments revenue was $1.749 billion.
Cardinal Health Reports Fourth-Quarter and Full-Year Results for Fiscal Year Ending June 30, 2023. Fourth-quarter revenue reached $53.453 billion, compared to $47.103 billion in the same period last year. The company reported a net loss of $64 million for the quarter, compared to a net profit of $138 million in the same period last year. Medical segment revenue for the quarter was $3.755 billion, compared to $3.769 billion in the same period last year. Full-year revenue amounted to $205 billion, up from $181.4 billion the previous year. Net profit attributable to the company for the fiscal year was $261 million, compared to a net loss of $933 million the previous year.Baxter International Inc. Announces Q2 2023 Financial Results. Net sales for the quarter were $3.707 billion, compared to $3.594 billion in the same period last year. Net loss attributable to shareholders for the quarter was $141 million, compared to a net profit of $252 million in the same period last year.Boston Scientific Announces Q2 2023 Financial Results. Net sales for the quarter were $3.599 billion, an increase of 11.0% compared to the same period last year. Net income attributable to common shareholders was $261 million, compared to $246 million in the prior year.Henry Schein Reports Q2 2023 Financial Results. Net sales for the quarter were $3.1 billion, compared to $3.03 billion in the same period last year. Net income attributable to the company for the quarter was $140 million, compared to $160 million in the same period last year.Owens & Minor Reports Q2 2023 Financial Results. Net sales for the quarter were $2.563 billion, compared to $2.5 billion in the same period last year. The company reported a net loss attributable to Owens & Minor of $28.2 million for the quarter, compared to a net profit of $28.6 million in the same period last year.3M Company Announces Q2 2023 Financial Results. Net sales for the quarter were $8.325 billion, compared to $8.702 billion in the same period last year. The company reported a net loss attributable to the company of $6.841 billion for the quarter, compared to a net profit of $78 million in the same period last year. Among these figures, healthcare business net sales were $2.075 billion, compared to $2.179 billion in the same period last year. Operating profit was $411 million, compared to $492 million in the same period last year.Zimmer Biomet Holdings Inc. Announces Q2 2023 Financial Results. Net sales for the quarter were $1.87 billion, compared to $1.78 billion in the same period last year. Net income attributable to the company for the quarter was $210 million, compared to $154 million in the same period last year.Terumo Reports First Quarter Financial Results for Fiscal Year Ending June 30, 2023. Quarterly revenue reached 215.3 billion yen (approximately 1.47 billion USD), compared to 197.3 billion yen in the same period last year, representing a 9.1% year-over-year increase. Quarterly operating profit was 29.644 billion yen, down 2.6% from 30.427 billion yen in the same period last year. Net profit attributable to parent company owners for the quarter was 22.549 billion yen, compared to 22.398 billion yen in the same period last year.
Olympus (OLYMPUS) Announces First Quarter Results for Fiscal Year Ending June 30, 2023. Quarterly revenue reached 207.7 billion yen (approximately 1.42 billion USD), compared to 192.3 billion yen in the same period last year, representing an 8% year-on-year increase. Quarterly operating profit was 22.476 billion yen, down 49.5% from 44.521 billion yen in the same period last year. Quarterly net profit attributable to parent company owners was 240.6 billion yen, up 867.7% from 24.86 billion yen in the same period last year.
Fujifilm Holdings announced its financial report for the first quarter of the fiscal year 2023, which ended on June 30, 2023. Quarterly sales revenue increased by 5.6% year-over-year, reaching 660.8 billion yen. Quarterly operating profit reached 52.2 billion yen, a year-over-year increase of 5.4%. Net profit attributable to the Fujifilm Group increased by 31.5% year-over-year, reaching 54.4 billion yen. Among the business segments, healthcare sales revenue increased by 13.1% year-over-year, reaching 206.8 billion yen (approximately 1.41 billion U.S. dollars). High-performance materials sales revenue decreased by 10.4% year-over-year, amounting to 154.6 billion yen. Imaging business sales revenue increased by 27.6% year-over-year, reaching 105.2 billion yen. Business innovation sales revenue increased by 3.2% year-over-year, totaling 194.2 billion yen.
Medical Device and Solutions Provider Mindray Medical Discloses 2023 Semi-Annual Report. During the reporting period, the company achieved operating revenue of 18.476 billion yuan (approximately 2.53 billion US dollars), a year-on-year increase of 20.32%; net profit attributable to shareholders of the listed company was 6.442 billion yuan, a year-on-year increase of 21.83%. In the first half of the year, Mindray Medical achieved revenues of 5.975 billion yuan and 3.701 billion yuan in the in vitro diagnostics and medical imaging businesses, respectively, representing year-on-year growth of 16.18% and 13.40%, respectively. The life information and support business achieved revenue of 8.667 billion yuan in the first half of the year, a year-on-year increase of 27.99%.
Canon Group Releases Q2 2023 Financial Report. In Q2, the group's revenue increased by 2.2% year-over-year to 1,020.882 billion yen. Net profit reached 65.4 billion yen, with a growth rate of 10.8%. In the printing business sector, quarterly revenue grew by 0.8% year-over-year to 574.9 billion yen. In the imaging business sector, revenue increased by 9.1% year-over-year to 219.2 billion yen. In the medical business sector, revenue rose by 6.7% year-over-year to 126.1 billion yen (approximately 860 million USD). In the industrial equipment and other products business sector, revenue declined by 4.4% year-over-year to 74.9 billion yen.EssilorLuxottica Releases Q2 2023 Financial Report. Total revenue for the quarter reached €6.699 billion, compared to €6.387 billion in the same period last year. Revenue from the professional sector was €3.208 billion (approximately $3.47 billion), while revenue from the consumer sector was €3.491 billion. Total revenue for the first half of the year amounted to €12.851 billion, compared to €11.994 billion in the same period last year. Net profit attributable to the parent company was €1.361 billion, compared to €1.174 billion in the same period last year.Alcon announced its financial results for the second quarter of 2023. Quarterly revenue was $2.422 billion, compared to $2.217 billion in the same period last year. Quarterly net profit was $169 million, compared to $148 million in the same period last year.Bausch+Lomb Reports Q2 2023 Financial Results. Revenue for the quarter was $1.035 billion, compared to $941 million in the same period last year. Net loss attributable to the company for the quarter was $32 million, compared to a net loss of $122 million in the same period last year.P R E V I E W
